Recon: FDA delays Novavax COVID vaccine approval; European drugmakers push for higher prices

• New England Journal of Medicine gets swept up in U.S. attorney inquiry into alleged bias (STAT)
• NIH chief voices support for Nora Volkow, head of drug addiction research institute (STAT)
• Roche seeks US tariff relief in direct talks with Trump administration (Reuters)
• As FDA delays Novavax' COVID vaccine approval, patients fight back (Reuters)
• Drugmakers brace for Trump tariffs with production shifts (Reuters)
• What To Do When You Receive a DEA Order to Show Cause (FDA Law Blog)
• US at tipping point for return of endemic measles (Reuters)

• Ireland’s Donohoe Says Watching US Companies for Reshoring (Endpoints)
• Tariffs Won't Bring US Allies On Board Against China (Endpoints)
• European pharma companies push for higher drug prices in EU amid US tariff threats (Reuters)
• Semaglutide For MASH Among Raft Of New EU Filings (Pink Sheet)
• Roche Q1 sales up 7% on drugs Phesgo, Vabysmo (Reuters)

• Eli Lilly opens a new legal front in its battle against compounded GLP-1s (STAT)
• Biotech is back, baby! It’s all upside from here (STAT)
• Tariff questions swirl around pharma earnings (STAT)
• Many young people want to quit vaping. A new study says medication can help (STAT)
• Merck Faces Lawsuit to Block Launch of Easier-to-Use Keytruda (Bloomberg)
• UPS Bolsters Health Unit With $1.6 Billion Deal for Andlauer (Bloomberg)
• Novo Nordisk's stellar Wegovy-fuelled run of hiking sales guidance could be ending (Reuters)
• Sanofi's quarterly profit boosted by Dupixent and newer drugs; forecast unchanged (Reuters)

• Danaher predicts $350M tariff hit, moves to mitigate impact on profits (MedTech Dive)
• Boston Scientific is ‘very bullish’ on 2025 despite $200M tariff hit (MedTech Dive)
• Intuitive lowers profit margin forecast due to tariff pressure (MedTech Dive)
• Field Medical raises $40M for PFA in ventricular tachycardia (MedTech Dive)
• ‘The FDA Will Be Looking For Avenues To Regulate Laboratory Developed Tests’ (MedTech Insight)

• FDA asks food industry to phase out artificial dyes (Food Dive)
• Food Industry Says There’s No Agreement With US Health Agency to Cut Dyes (Bloomberg)

• UnitedHealth discloses $1.7 million in security spending after slaying of top exec (STAT)
• Studies zoom in on clues to why Lyme disease persists and which antibiotic to prescribe (STAT)
• As Republicans push work requirements in Medicaid, Arkansas offers a cautionary tale (STAT)
• The volunteer committee advising on newborn screening must be reinstated (STAT)
• Former Trump official warns president he’s at risk of ruining his legacy on ending HIV (STAT)